Physician profile
David E Haynes
NPI 1811995038
$9,515.64
in general payments reported to CMS, 2019-2025
9 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,667 · 2020: $3,214 · 2022: $1,281 · 2023: $2,106 · 2024: $92.37 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,357 · Food and Beverage: $996.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,357.43 |
| Food and Beverage | $996.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $6,089.80 | 2019-2025 | |
| Arthrex, INC. | $2,544.06 | 2019-2023 | Knee & Hip Implants Meniscal Repair Fiberstitch |
| Stryker Corporation | $710.16 | 2022-2023 | Clarifix Cryotherapy Device |
| Djo, LLC | $68.59 | 2019 | |
| Smith+Nephew, INC. | $31.20 | 2022-2025 | |
| Pacira Pharmaceuticals Incorporated | $25.62 | 2024 | Zilretta, Iovera, Exparel |
| Vericel Corporation | $18.40 | 2019 | |
| Pacira Therapeutics, INC. | $14.07 | 2019 | |
| Anika Therapeutics, INC. | $13.74 | 2023 | Revomotion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Haynes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.